Concepedia

Yukie Kashima

YK

Statistics

Publications

19

Citations

1.5K

H-Index

16

Active since

2014

Affiliations

The University of Tokyo(Current)

National Cancer Center Hospital East

Chiba Cancer Center

Kyoto University

National Institute of Infectious Diseases

Yukie Kashima is an author at The University of Tokyo specializing in life sciences, molecular biology, and oncology.

Publications per year

2014–2024

19

Publications

19

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Rigel Suzuki, Daichi Yamasoba, Izumi Kimura et al. · Nature · 2022 · 749 citations · Full text

, , +9

Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Yukie Kashima, Daisuke Shibahara, Ayako Suzuki et al. · Cancer Research · 2021 · 104 citations · Full text

, , +17

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

Monique B. Nilsson, Yan Yang, Simon Heeke et al. · Cancer Cell · 2023 · 104 citations · Full text

, , +12

Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells

Yumi Fujimoto, Tomoko Morita, Akihiro Ohashi et al. · Scientific Reports · 2020 · 89 citations · Full text

, , +15

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5

Tomokazu Tamura, Daichi Yamasoba, Yoshitaka Oda et al. · Communications Biology · 2023 · 64 citations · Full text

, , +17

1–5 of 19